Approval · Notice of Compliance 502 · 2002
MODECATE: Notice of Compliance 502
Issued August 20, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 502
- Date
- August 20, 2002
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the dosage & administration section of the product monograph regarding elderly and poor risk patients
- Therapeutic class
- Antipsychotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MODECATE | Not yet assigned | — |
| MODECATE CONCENTRATE | Not yet assigned | — |
Medicinal ingredients
- FLUPHENAZINE DECANOATE 25 MG per ML
- FLUPHENAZINE DECANOATE 100 MG per ML